Apollo Hospitals’ energy arm to sell 23.3% stake to German partner Munich Re


Apollo Energy Company, a group of Apollo Hospitals, will sell 23.3% of its shareholding in Apollo Munich Health Insurance company to its German partner Munich Re for Rs 163.5 crore. Post the transaction, Munich Re’s stake in the insurance joint venture (JV) will increase to 48.7%.

Subject to various approvals, the deal is expected to be complete by the end of the first quarter of 2016, according to a statement.

“The Board of Directors of Apollo Energy Company Ltd, an Apollo Hospitals Group company, at a meeting held on Monday, approved the divestment of 23.3% shareholding in Apollo Munich Health Insurance Company Ltd (Apollo Munich) to its joint venture partner, Munich Re of Germany for Rs 163.5 crore,” it said. The proposed transaction values Apollo Munich at Rs 703 crore.

“Post consummation of the transaction, Apollo Hospitals Group’s shareholding in Apollo Munich shall stand reduced from 74.4% to 51.1%.”

ALSO READ: IT department raids Apollo Hospitals in New Delhi, other cities

“Correspondingly, Munich Re’s shareholding in Apollo Munich shall move to 48.7% and 0.2% will be held by employees. Apollo Hospitals shall continue to hold its stake in Apollo Munich,” the statement added.

Prathap C Reddy, Chairman, Apollo Munich and Chairman, Apollo Hospitals Enterprise said, “The show of confidence from our JV partner will go a long way in helping the Group achieve its vision of ‘Healthcare for all’.”

The government in March 2015 increased the Foreign Direct Investment (FDI) cap in the insurance sector from 26% to 49%.

“With the increased stakeholding, we are strengthening our position for sustainable and profitable growth in this region. Apollo Munich Health Insurance is committed to making quality healthcare easy and accessible,” said Doris Hoepke, the member of the Munich Re Board of Management responsible for Munich Health.

On Tuesday, at 1035 hours, the shares of Apollo Hospitals Enterprise were trading up 0.78% or Rs 11.10 at Rs 1,431.00 per scrip intraday on the BSE.